Literature DB >> 3698366

Tumor-induced platelet aggregation and growth promoting factors as determinants for successful tumor metastasis.

T Tsuruo, H Kawabata, H Iida, T Yamori.   

Abstract

Two clones isolated from a metastatic variant of mouse colon adenocarcinoma 26; the high metastatic NL-17 and the low metastatic NL-44, induced similar platelet aggregation in vitro. Heterotypic aggregates of tumor cells and platelets were injected i.v. into mice. The lung colonization potential of the NL-17 was dependent on the extent of tumor cell platelet aggregation. This clearly indicates that the interaction of tumor cells with platelets can lead to enhanced tumor metastasis possibly through more efficient intravascular arrest of the heterotypic aggregates. The interaction of tumor cells with platelets could thus be an important determinant for successful metastasis. NL-44, however, did not form pulmonary metastasis even after the tumor cells formed heterotypic aggregates with platelets, suggesting that tumor metastasis, is dependent on the intrinsic nature of tumor cells. Lung extract enhanced the growth of NL-17 more effectively than that of NL-44. These results suggest that, in addition to the interaction of metastatic cells and platelets, host factors including growth-promoting factors might also have an important role in tumor metastasis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3698366     DOI: 10.1007/bf00053470

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  23 in total

1.  Demonstration of fibrin in early stages of experimental metastases.

Authors:  E C Chew; A C Wallace
Journal:  Cancer Res       Date:  1976-06       Impact factor: 12.701

2.  Aspirin and tumour metastasis.

Authors:  S Wood; P Hilgard
Journal:  Lancet       Date:  1972-12-30       Impact factor: 79.321

3.  Adhesive properties of weakly and highly metastatic melanoma cell lines.

Authors:  H Urushihara; Y Ikawa; T Tsuruo
Journal:  Gan       Date:  1984-06

Review 4.  Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells.

Authors:  G L Nicolson
Journal:  Biochim Biophys Acta       Date:  1982-12-21

5.  Platelets as a source of growth-promoting factor(s) for tumor cells.

Authors:  Y Hara; M Steiner; M G Baldini
Journal:  Cancer Res       Date:  1980-04       Impact factor: 12.701

6.  Effect of ditazole, an inhibitor of platelet aggregation, on a metastasizing tumour in mice.

Authors:  L Mussoni; A Poggi; G De Gaetano; M B Donati
Journal:  Br J Cancer       Date:  1978-01       Impact factor: 7.640

7.  Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26.

Authors:  T Tsuruo; T Yamori; K Naganuma; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1983-11       Impact factor: 12.701

8.  Platelet-tumor-cell interactions in mice. The role of platelets in the spread of malignant disease.

Authors:  G J Gasic; T B Gasic; N Galanti; T Johnson; S Murphy
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

Review 9.  Cell surface molecules and tumor metastasis. Regulation of metastatic phenotypic diversity.

Authors:  G L Nicolson
Journal:  Exp Cell Res       Date:  1984-01       Impact factor: 3.905

10.  Effects of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor, on blood-borne metastasis.

Authors:  S Kohga; M Kinjo; K Tanaka; H Ogawa; M Ishihara; N Tanaka
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

View more
  12 in total

1.  Growth stimulating activity of lung extract on lung-colonizing colon 26 clones and its partial characterization.

Authors:  T Yamori; H Iida; S Tsukagoshi; T Tsuruo
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

2.  Inhibition of lung colonization of mouse colon 26 adenocarcinoma by recombinant mouse interferon beta through a modification of platelet function.

Authors:  T Tsuruo; H Saito; M Watanabe; Y Sugimoto; T Yamori; T Oh-Hara
Journal:  Clin Exp Metastasis       Date:  1990 Mar-Apr       Impact factor: 5.150

3.  The lack of correlation between experimental metastatic potential and platelet aggregating activity of B16 melanoma clones viewed in relation to tumor cell heterogeneity.

Authors:  A K Kimura; P Mehta; J H Xiang; D Lawson; D Dugger; K J Kao; L Lee-Ambrose
Journal:  Clin Exp Metastasis       Date:  1987 Apr-Jun       Impact factor: 5.150

Review 4.  Brain metastases: biology and the role of the brain microenvironment.

Authors:  V K Puduvalli
Journal:  Curr Oncol Rep       Date:  2001-11       Impact factor: 5.075

5.  Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis.

Authors:  Elisabeth M Battinelli; Beth A Markens; Joseph E Italiano
Journal:  Blood       Date:  2011-06-16       Impact factor: 22.113

6.  Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis.

Authors:  T Mishima; J Murata; M Toyoshima; H Fujii; M Nakajima; T Hayashi; T Kato; I Saiki
Journal:  Clin Exp Metastasis       Date:  1998-08       Impact factor: 5.150

Review 7.  Platelets and cancer metastasis: a causal relationship?

Authors:  K V Honn; D G Tang; J D Crissman
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

Review 8.  The role of membrane mucin MUC4 in breast cancer metastasis.

Authors:  Courtney A Dreyer; Kacey VanderVorst; Savannah Free; Ashley Rowson-Hodel; Kermit L Carraway
Journal:  Endocr Relat Cancer       Date:  2021-11-24       Impact factor: 5.678

9.  Insulin and insulin-like growth factor 1 stimulate proliferation of metastatic variants of colon carcinoma 26.

Authors:  M Koenuma; T Yamori; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1989-01

Review 10.  Platelet aggregation in the formation of tumor metastasis.

Authors:  Takashi Tsuruo; Naoya Fujita
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2008       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.